Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07285421Not ApplicableNot Yet Recruiting

Renal and Vascular Phenotypic Characterization of Patients With Enamel Renal Syndrome Due to a Pathogenic Variant of the FAM20A Gene and Pathophysiological Study of Ectopic Calcifications

Role: collaborator

NCT05133999Completed

Iron and Retinopathy of Prematurity (ROP)

Role: collaborator

NCT04418375Completed

Establishment of a Biological Collection During COVID-19 Serological Screening in APHP Professionals (COVID-HOP)

Role: collaborator

NCT05258370Not Yet Recruiting

Fibroblast Growth Factor 23 in Chronic Respiratory Failure

Role: collaborator

All 4 trials loaded